Literature DB >> 12692068

TPMT in the treatment of inflammatory bowel disease with azathioprine.

A Qasim, J Seery, M Buckley, C O Morain.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12692068      PMCID： PMC1773647          DOI： 10.1136/gut.52.5.767

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  10 in total

Review 1.  Management of Crohn's disease in adults.

Authors:  S B Hanauer; W Sandborn
Journal:  Am J Gastroenterol       Date:  2001-03       Impact factor: 10.864

2.  Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy.

Authors:  J F Colombel; N Ferrari; H Debuysere; P Marteau; J P Gendre; B Bonaz; J C Soulé; R Modigliani; Y Touze; P Catala; C Libersa; F Broly
Journal:  Gastroenterology       Date:  2000-06       Impact factor: 22.682

3.  Olsalazine and 6-mercaptopurine-related bone marrow suppression: a possible drug-drug interaction.

Authors:  L D Lewis; A Benin; C L Szumlanski; D M Otterness; L Lennard; R M Weinshilboum; D W Nierenberg
Journal:  Clin Pharmacol Ther       Date:  1997-10       Impact factor: 6.875

4.  Relevance of thiopurine methyltransferase activity in inflammatory bowel disease patients maintained on low-dose azathioprine.

Authors:  S Campbell; K Kingstone; S Ghosh
Journal:  Aliment Pharmacol Ther       Date:  2002-03       Impact factor: 8.171

5.  Azathioprine therapy and adverse drug reactions in patients with inflammatory bowel disease: impact of thiopurine S-methyltransferase polymorphism.

Authors:  Matthias Schwab; Elke Schäffeler; Claudia Marx; Christine Fischer; Thomas Lang; Christoph Behrens; Michael Gregor; Michel Eichelbaum; Ulrich M Zanger; Bernd A Kaskas
Journal:  Pharmacogenetics       Date:  2002-08

6.  Bone marrow toxicity caused by azathioprine in inflammatory bowel disease: 27 years of experience.

Authors:  W R Connell; M A Kamm; J K Ritchie; J E Lennard-Jones
Journal:  Gut       Date:  1993-08       Impact factor: 23.059

7.  Thiopurine methyltransferase genotype predicts therapy-limiting severe toxicity from azathioprine.

Authors:  A J Black; H L McLeod; H A Capell; R H Powrie; L K Matowe; S C Pritchard; E S Collie-Duguid; D M Reid
Journal:  Ann Intern Med       Date:  1998-11-01       Impact factor: 25.391

8.  Azathioprine-induced myelosuppression due to thiopurine methyltransferase deficiency in a patient with autoimmune hepatitis.

Authors:  Z Ben Ari; A Mehta; L Lennard; A K Burroughs
Journal:  J Hepatol       Date:  1995-09       Impact factor: 25.083

9.  Pharmacogenetics of acute azathioprine toxicity: relationship to thiopurine methyltransferase genetic polymorphism.

Authors:  L Lennard; J A Van Loon; R M Weinshilboum
Journal:  Clin Pharmacol Ther       Date:  1989-08       Impact factor: 6.875

Review 10.  Pancytopenia related to azathioprine--an enzyme deficiency caused by a common genetic polymorphism: a review.

Authors:  A Anstey; L Lennard; S C Mayou; J D Kirby
Journal:  J R Soc Med       Date:  1992-12       Impact factor: 18.000
  10 in total
  5 in total

1.  Azathioprine-related myelosuppression in a patient homozygous for TPMT*3A.

Authors:  Pooja Budhiraja; Mordecai Popovtzer
Journal:  Nat Rev Nephrol       Date:  2011-06-28       Impact factor: 28.314

Review 2.  The thiopurines: an update.

Authors:  Sally Coulthard; Linda Hogarth
Journal:  Invest New Drugs       Date:  2005-12       Impact factor: 3.850

3.  The long-term risk of continuous immunosuppression using thioguanides in inflammatory bowel disease.

Authors:  Anthony O'Connor; Asghar Qasim; Colm A O'Moráin
Journal:  Ther Adv Chronic Dis       Date:  2010-01       Impact factor: 5.091

4.  Genotype-Guided Thiopurine Dosing Does not Lead to Additional Costs in Patients With Inflammatory Bowel Disease.

Authors:  Reinier L Sluiter; Corine Van Marrewijk; Dirk De Jong; Hans Scheffer; Henk-Jan Guchelaar; Luc Derijks; Dennis R Wong; Piet Hooymans; Sita H Vermeulen; André L M Verbeek; Barbara Franke; Gert Jan Van der Wilt; Wietske Kievit; Marieke J H Coenen
Journal:  J Crohns Colitis       Date:  2019-07-25       Impact factor: 9.071

Review 5.  Thiopurine monitoring in children with inflammatory bowel disease: a systematic review.

Authors:  Anastasia Konidari; Antonios Anagnostopoulos; Laura J Bonnett; Munir Pirmohamed; Wael El-Matary
Journal:  Br J Clin Pharmacol       Date:  2014-09       Impact factor: 4.335
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.